Bristol-Myers Squibb Company (BMY) Q3 2018 Earnings Results

Bristol Myers Squibb Beats on EPS, Stock Up 0.78%

Bristol Myers Squibb's earnings report shows a strong performance in EPS, exceeding expectations. The stock reacted positively, increasing by 0.78%. This suggests investor confidence in the company's current trajectory, although no guidance was offered for future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.09	N/A	+14.96%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting the strength of their product pipeline. They emphasized their commitment to driving future growth.

We are pleased with our EPS performance this quarter.

Our focus remains on delivering value through our innovative pipeline.

Bristol Myers Squibb Beats on EPS, Stock Up 0.78%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol Myers Squibb Beats on EPS, Stock Up 0.78%

Key numbers

Management commentary